-
1
-
-
0037114705
-
Invasive aspergillosis in allogeneic stem cell transplantation recipients; Changes in epidemiology and risk factors
-
PMid:12393425
-
Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplantation recipients; Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366. http://dx.doi.org/10.1182/blood-2002-05-1496 PMid:12393425
-
(2002)
Blood
, vol.100
, pp. 4358-4366
-
-
Marr, K.A.1
Carter, R.A.2
Boeckh, M.3
Martin, P.4
Corey, L.5
-
2
-
-
33751055610
-
Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes
-
Sanz MA, Jarque I, Salavert M, Pemán J. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clin Microbiol Infect 2006; 12 (Suppl 7): 2-6. http://dx.doi.org/10.1111/j.1469-0691.2006.01602.x
-
(2006)
Clin Microbiol Infect
, vol.12
, Issue.SUPPL. 7
, pp. 2-6
-
-
Sanz, M.A.1
Jarque, I.2
Salavert, M.3
Pemán, J.4
-
3
-
-
58749083534
-
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry
-
PMid:19115967
-
Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009;48:265-73. http://dx.doi.org/10.1086/595846 PMid:19115967
-
(2009)
Clin Infect Dis
, vol.48
, pp. 265-273
-
-
Neofytos, D.1
Horn, D.2
Anaissie, E.3
Steinbach, W.4
Olyaei, A.5
Fishman, J.6
Pfaller, M.7
Chang, C.8
Webster, K.9
Marr, K.10
-
4
-
-
0035109799
-
Aspergillosis case-fatality rate: systematic review of the literature
-
PMid:11170942
-
Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-366. http://dx.doi.org/10.1086/318483 PMid:11170942
-
(2001)
Clin Infect Dis
, vol.32
, pp. 358-366
-
-
Lin, S.J.1
Schranz, J.2
Teutsch, S.M.3
-
5
-
-
33846934215
-
Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality
-
PMid:17243056
-
Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007;44:531-540. http://dx.doi.org/10.1086/510592 PMid:17243056
-
(2007)
Clin Infect Dis
, vol.44
, pp. 531-540
-
-
Upton, A.1
Kirby, K.A.2
Carpenter, P.3
Boeckh, M.4
Marr, K.A.5
-
6
-
-
23844464106
-
Epidemiology and outcome of zygomycosis: a review of 929 reported cases
-
PMid:16080086
-
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653. http://dx.doi.org/10.1086/432579 PMid:16080086
-
(2005)
Clin Infect Dis
, vol.41
, pp. 634-653
-
-
Roden, M.M.1
Zaoutis, T.E.2
Buchanan, W.L.3
Knudsen, T.A.4
Sarkisova, T.A.5
Schaufele, R.L.6
Sein, M.7
Sein, T.8
Chiou, C.C.9
Chu, J.H.10
Kontoyiannis, D.P.11
Walsh, T.J.12
-
7
-
-
0033545538
-
National Institute of Allergy and Infectious Diseases Mycoses Study Group. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
-
PMid:10072411
-
Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999; 340: 764-771. http://dx.doi.org/10.1056/NEJM199903113401004 PMid:10072411
-
(1999)
N Engl J Med
, vol.340
, pp. 764-771
-
-
Walsh, T.J.1
Finberg, R.W.2
Arndt, C.3
Hiemenz, J.4
Schwartz, C.5
Bodensteiner, D.6
Pappas, P.7
Seibel, N.8
Greenberg, R.N.9
Dummer, S.10
Schuster, M.11
Holcenberg, J.S.12
-
8
-
-
0037165259
-
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
-
PMid:11807146
-
Walsh TJ, Pappas P, Winston DJ, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdière M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-234. http://dx.doi.org/10.1056/NEJM200201243460403 PMid:11807146
-
(2002)
N Engl J Med
, vol.346
, pp. 225-234
-
-
Walsh, T.J.1
Pappas, P.2
Winston, D.J.3
Petersen, F.4
Raffalli, J.5
Yanovich, S.6
Stiff, P.7
Greenberg, R.8
Donowitz, G.9
Schuster, M.10
Reboli, A.11
Wingard, J.12
Arndt, C.13
Reinhardt, J.14
Hadley, S.15
Finberg, R.16
Laverdière, M.17
Perfect, J.18
Garber, G.19
Fioritoni, G.20
Anaissie, E.21
Lee, J.22
more..
-
9
-
-
4644346490
-
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
-
PMid:15459300
-
Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402. http://dx.doi.org/10.1056/NEJMoa040446 PMid:15459300
-
(2004)
N Engl J Med
, vol.351
, pp. 1391-1402
-
-
Walsh, T.J.1
Teppler, H.2
Donowitz, G.R.3
Maertens, J.A.4
Baden, L.R.5
Dmoszynska, A.6
Cornely, O.A.7
Bourque, M.R.8
Lupinacci, R.J.9
Sable, C.A.10
de Pauw, B.E.11
-
10
-
-
27444447144
-
Galactomannan and computer tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
-
PMid:16206097
-
Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and computer tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250. http://dx.doi.org/10.1086/496927 PMid:16206097
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1242-1250
-
-
Maertens, J.1
Theunissen, K.2
Verhoef, G.3
Verschakelen, J.4
Lagrou, K.5
Verbeken, E.6
Wilmer, A.7
Verhaegen, J.8
Boogaerts, M.9
Van Eldere, J.10
-
11
-
-
63649156819
-
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial
-
PMid:19281327
-
Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis. 2009; 48:1042-1051. http://dx.doi.org/10.1086/597395 PMid:19281327
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1042-1051
-
-
Cordonnier, C.1
Pautas, C.2
Maury, S.3
Vekhoff, A.4
Farhat, H.5
Suarez, F.6
Dhédin, N.7
Isnard, F.8
Ades, L.9
Kuhnowski, F.10
Foulet, F.11
Kuentz, M.12
Maison, P.13
Bretagne, S.14
Schwarzinger, M.15
-
12
-
-
77449124531
-
Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study
-
PMid:19841328
-
Girmenia C, Micozzi A, Gentile G, Santilli S, Arleo E, Cardarelli L, Capria S, Minotti C, Cartoni C, Brocchieri S, Guerrisi V, Meloni G, Foà R, Martino P. Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study. J Clin Oncol 2010;28:667-674. http://dx.doi.org/10.1200/JCO.2009.21.8032 PMid:19841328
-
(2010)
J Clin Oncol
, vol.28
, pp. 667-674
-
-
Girmenia, C.1
Micozzi, A.2
Gentile, G.3
Santilli, S.4
Arleo, E.5
Cardarelli, L.6
Capria, S.7
Minotti, C.8
Cartoni, C.9
Brocchieri, S.10
Guerrisi, V.11
Meloni, G.12
Foà, R.13
Martino, P.14
-
13
-
-
80052355809
-
HEMA e-Chart Group. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project
-
PMid:21565903 PMCid:3166108
-
Pagano L, Caira M, Nosari A, Cattaneo C, Fanci R, Bonini A, Vianelli N, Garzia MG, Mancinelli M, Tosti ME, Tumbarello M, Viale P, Aversa F, Rossi G; HEMA e-Chart Group. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica 2011;96:1366-1370. http://dx.doi.org/10.3324/haematol.2011.042598 PMid:21565903 PMCid:3166108
-
(2011)
Haematologica
, vol.96
, pp. 1366-1370
-
-
Pagano, L.1
Caira, M.2
Nosari, A.3
Cattaneo, C.4
Fanci, R.5
Bonini, A.6
Vianelli, N.7
Garzia, M.G.8
Mancinelli, M.9
Tosti, M.E.10
Tumbarello, M.11
Viale, P.12
Aversa, F.13
Rossi, G.14
-
14
-
-
0037736664
-
Intravenous and oral itraconazole versus intravenous and oral fluconazole for longterm antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients: a multicenter, radomized trial
-
PMid:12729424
-
Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC. Intravenous and oral itraconazole versus intravenous and oral fluconazole for longterm antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients: a multicenter, radomized trial. Ann Intern Med 2003; 138: 705-713. PMid:12729424
-
(2003)
Ann Intern Med
, vol.138
, pp. 705-713
-
-
Winston, D.J.1
Maziarz, R.T.2
Chandrasekar, P.H.3
Lazarus, H.M.4
Goldman, M.5
Blumer, J.L.6
Leitz, G.J.7
Territo, M.C.8
-
15
-
-
33745258668
-
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis
-
PMid:16626917
-
Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M, Diekema DJ. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microbiol Infect Dis 2006; 55: 209-212. http://dx.doi.org/10.1016/j.diagmicrobio.2006.01.018 PMid:16626917
-
(2006)
Diagn Microbiol Infect Dis
, vol.55
, pp. 209-212
-
-
Siwek, G.T.1
Pfaller, M.A.2
Polgreen, P.M.3
Cobb, S.4
Hoth, P.5
Magalheas-Silverman, M.6
Diekema, D.J.7
-
16
-
-
78650058029
-
Randomized double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogenic hematopoietic cell transplantation
-
PMid:20826719 PMCid:3012532
-
Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather HL, Confer DL, Maziarz RT, Stadtmauer EA, Bolaños-Meade J, Brown J, Dipersio JF, Boeckh M, Marr KA. Randomized double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogenic hematopoietic cell transplantation. Blood 2010; 116: 5111-5118. http://dx.doi.org/10.1182/blood-2010-02-268151 PMid:20826719 PMCid:3012532
-
(2010)
Blood
, vol.116
, pp. 5111-5118
-
-
Wingard, J.R.1
Carter, S.L.2
Walsh, T.J.3
Kurtzberg, J.4
Small, T.N.5
Baden, L.R.6
Gersten, I.D.7
Mendizabal, A.M.8
Leather, H.L.9
Confer, D.L.10
Maziarz, R.T.11
Stadtmauer, E.A.12
Bolaños-Meade, J.13
Brown, J.14
Dipersio, J.F.15
Boeckh, M.16
Marr, K.A.17
-
17
-
-
76249128351
-
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia
-
PMid:19878274
-
Torres A, Serrano J, Rojas R, Martín V, Martín C, Tabares S, Molina JR, Capote M, Martínez F, Gómez P, Sánchez-García J. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. Eur J Haematol 2009; 84: 271-273. http://dx.doi.org/10.1111/j.1600-0609.2009.01367.x PMid:19878274
-
(2009)
Eur J Haematol
, vol.84
, pp. 271-273
-
-
Torres, A.1
Serrano, J.2
Rojas, R.3
Martín, V.4
Martín, C.5
Tabares, S.6
Molina, J.R.7
Capote, M.8
Martínez, F.9
Gómez, P.10
Sánchez-García, J.11
-
18
-
-
33846462456
-
Posaconazole vs fluconazole or itraconazole prophylaxis in patientswith neutropenia
-
PMid:17251531
-
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D. Posaconazole vs fluconazole or itraconazole prophylaxis in patientswith neutropenia. N Engl J Med 2007; 356: 348-359. http://dx.doi.org/10.1056/NEJMoa061094 PMid:17251531
-
(2007)
N Engl J Med
, vol.356
, pp. 348-359
-
-
Cornely, O.A.1
Maertens, J.2
Winston, D.J.3
Perfect, J.4
Ullmann, A.J.5
Walsh, T.J.6
Helfgott, D.7
Holowiecki, J.8
Stockelberg, D.9
Goh, Y.T.10
Petrini, M.11
Hardalo, C.12
Suresh, R.13
Angulo-Gonzalez, D.14
-
19
-
-
33846410666
-
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
-
PMid:17251530
-
Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335-347. http://dx.doi.org/10.1056/NEJMoa061098 PMid:17251530
-
(2007)
N Engl J Med
, vol.356
, pp. 335-347
-
-
Ullmann, A.J.1
Lipton, J.H.2
Vesole, D.H.3
Chandrasekar, P.4
Langston, A.5
Tarantolo, S.R.6
Greinix, H.7
Morais de Azevedo, W.8
Reddy, V.9
Boparai, N.10
Pedicone, L.11
Patino, H.12
Durrant, S.13
-
20
-
-
0037043655
-
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
-
PMid:12167683
-
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415. http://dx.doi.org/10.1056/NEJMoa020191 PMid:12167683
-
(2002)
N Engl J Med
, vol.347
, pp. 408-415
-
-
Herbrecht, R.1
Denning, D.W.2
Patterson, T.F.3
Bennett, J.E.4
Greene, R.E.5
Oestmann, J.W.6
Kern, W.V.7
Marr, K.A.8
Ribaud, P.9
Lortholary, O.10
Sylvester, R.11
Rubin, R.H.12
Wingard, J.R.13
Stark, P.14
Durand, C.15
Caillot, D.16
Thiel, E.17
Chandrasekar, P.H.18
Hodges, M.R.19
Schlamm, H.T.20
Troke, P.F.21
de Pauw, B.22
more..
-
21
-
-
84857466597
-
Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic stem cell transplant (HSCT) recipients vs other patients with aspergillosis
-
Van Burik JA, Perfect J, Louie A, Graybill JR, Pedicone L, Raad II. Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic stem cell transplant (HSCT) recipients vs other patients with aspergillosis. Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 137. http://dx.doi.org/10.1016/j.bbmt.2005.11.420
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, Issue.SUPPL. 1
, pp. 137
-
-
Van Burik, J.A.1
Perfect, J.2
Louie, A.3
Graybill, J.R.4
Pedicone, L.5
Raad, I.I.6
-
22
-
-
84857473278
-
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
-
Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002; 44: 2-12.
-
(2002)
Clin Infect Dis
, vol.44
, pp. 2-12
-
-
Denning, D.W.1
Ribaud, P.2
Milpied, N.3
Caillot, D.4
Herbrecht, R.5
Thiel, E.6
Haas, A.7
Ruhnke, M.8
Lode, H.9
-
23
-
-
33748569923
-
Flynn PM, van Burik JA, Buell DN, Patterson TF. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
-
PMid:16678903
-
Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, Ullmann AJ, Seibel NL, Flynn PM, van Burik JA, Buell DN, Patterson TF. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J Infect. 2006; 53: 337-349. http://dx.doi.org/10.1016/j.jinf.2006.03.003 PMid:16678903
-
(2006)
J Infect
, vol.53
, pp. 337-349
-
-
Denning, D.W.1
Marr, K.A.2
Lau, W.M.3
Facklam, D.P.4
Ratanatharathorn, V.5
Becker, C.6
Ullmann, A.J.7
Seibel, N.L.8
-
24
-
-
0037669567
-
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
-
PMid:12872348
-
Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 2003; 98: 292-299. http://dx.doi.org/10.1002/cncr.11479 PMid:12872348
-
(2003)
Cancer
, vol.98
, pp. 292-299
-
-
Kontoyiannis, D.P.1
Hachem, R.2
Lewis, R.E.3
Rivero, G.A.4
Torres, H.A.5
Thornby, J.6
Champlin, R.7
Kantarjian, H.8
Bodey, G.P.9
Raad, I.I.10
-
25
-
-
0037441932
-
Refractory aspergillus pneumonia in patients with acute leukemia
-
PMid:12569602
-
Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA. Refractory aspergillus pneumonia in patients with acute leukemia. Cancer 2003; 97: 1025-1032. http://dx.doi.org/10.1002/cncr.11115 PMid:12569602
-
(2003)
Cancer
, vol.97
, pp. 1025-1032
-
-
Aliff, T.B.1
Maslak, P.G.2
Jurcic, J.G.3
Heaney, M.L.4
Cathcart, K.N.5
Sepkowitz, K.A.6
Weiss, M.A.7
-
26
-
-
4544236836
-
Combination antifungal therapy for invasive aspergillosis
-
PMid:15472810
-
Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004; 39: 797-802. http://dx.doi.org/10.1086/423380 PMid:15472810
-
(2004)
Clin Infect Dis
, vol.39
, pp. 797-802
-
-
Marr, K.A.1
Boeckh, M.2
Carter, R.A.3
Kim, H.W.4
Corey, L.5
-
27
-
-
32844474763
-
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective multicenter, observational study
-
PMid:16477215
-
Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective multicenter, observational study. Transplantation 2006; 81: 320-326. http://dx.doi.org/10.1097/01.tp.0000202421.94822.f7 PMid:16477215
-
(2006)
Transplantation
, vol.81
, pp. 320-326
-
-
Singh, N.1
Limaye, A.P.2
Forrest, G.3
Safdar, N.4
Muñoz, P.5
Pursell, K.6
Houston, S.7
Rosso, F.8
Montoya, J.G.9
Patton, P.10
Del Busto, R.11
Aguado, J.M.12
Fisher, R.A.13
Klintmalm, G.B.14
Miller, R.15
Wagener, M.M.16
Lewis, R.E.17
Kontoyiannis, D.P.18
Husain, S.19
-
28
-
-
33845574728
-
Multicenter, noncomparative study of caspofungin in combination with others antifungals as salvage therapy in adults with invasive aspergillosis
-
PMid:17103444
-
Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cordonnier C, Segal BH, Killar J, Taylor A, Kartsonis N, Patterson TF, Aoun M, Caillot D, Sable C. Multicenter, noncomparative study of caspofungin in combination with others antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 2006; 107: 2888-2897. http://dx.doi.org/10.1002/cncr.22348 PMid:17103444
-
(2006)
Cancer
, vol.107
, pp. 2888-2897
-
-
Maertens, J.1
Glasmacher, A.2
Herbrecht, R.3
Thiebaut, A.4
Cordonnier, C.5
Segal, B.H.6
Killar, J.7
Taylor, A.8
Kartsonis, N.9
Patterson, T.F.10
Aoun, M.11
Caillot, D.12
Sable, C.13
-
29
-
-
34249709522
-
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
-
PMid:17442100 PMCid:1871594
-
Cesaro S, Giacchino M, Locatelli F, Spiller M, Buldini B, Castellini C, Caselli D, Giraldi E, Tucci F, Tridello G, Rossi MR, Castagnola E. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. BMC Infect Dis 2007; 7: 28-38. http://dx.doi.org/10.1186/1471-2334-7-28 PMid:17442100 PMCid:1871594
-
(2007)
BMC Infect Dis
, vol.7
, pp. 28-38
-
-
Cesaro, S.1
Giacchino, M.2
Locatelli, F.3
Spiller, M.4
Buldini, B.5
Castellini, C.6
Caselli, D.7
Giraldi, E.8
Tucci, F.9
Tridello, G.10
Rossi, M.R.11
Castagnola, E.12
-
30
-
-
53649100394
-
A clinical cohort trial of antifungal combination therapy: Efficacy and toxicity in hematological cancer patients
-
PMid:18641986
-
Rieger CT, Ostermann H, Kolb HJ, Fiegl M, Huppmann S, Morgenstern N, Tischer J. A clinical cohort trial of antifungal combination therapy: Efficacy and toxicity in hematological cancer patients. Ann Hematol 2008; 87: 915-922. http://dx.doi.org/10.1007/s00277-008-0534-4 PMid:18641986
-
(2008)
Ann Hematol
, vol.87
, pp. 915-922
-
-
Rieger, C.T.1
Ostermann, H.2
Kolb, H.J.3
Fiegl, M.4
Huppmann, S.5
Morgenstern, N.6
Tischer, J.7
-
31
-
-
37049003816
-
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies. A randomized pilot study (Combistrat trials)
-
PMid:17941026
-
Caillot D, Thiebaut A, Herbrecht R, de Botton S, Pigneux A, Bernard F, Larché J, Monchecourt F, Alfandari S, Mahi L. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies. A randomized pilot study (Combistrat trials). Cancer 2007; 110: 2740-2746. http://dx.doi.org/10.1002/cncr.23109 PMid:17941026
-
(2007)
Cancer
, vol.110
, pp. 2740-2746
-
-
Caillot, D.1
Thiebaut, A.2
Herbrecht, R.3
de Botton, S.4
Pigneux, A.5
Bernard, F.6
Larché, J.7
Monchecourt, F.8
Alfandari, S.9
Mahi, L.10
-
32
-
-
79952190110
-
Use of antifungal combination therapy: agents, order, and timing
-
PMid:20574543 PMCid:2889487
-
Johnson MD, Perfect JR. Use of antifungal combination therapy: agents, order, and timing. Curr Fungal Infect Rep. 2010;4:87-95. http://dx.doi.org/10.1007/s12281-010-0018-6 PMid:20574543 PMCid:2889487
-
(2010)
Curr Fungal Infect Rep
, vol.4
, pp. 87-95
-
-
Johnson, M.D.1
Perfect, J.R.2
-
33
-
-
46249126149
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
-
PMid:18462102 PMCid:2671227
-
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821. http://dx.doi.org/10.1086/588660 PMid:18462102 PMCid:2671227
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1813-1821
-
-
De Pauw, B.1
Walsh, T.J.2
Donnelly, J.P.3
Stevens, D.A.4
Edwards, J.E.5
Calandra, T.6
Pappas, P.G.7
Maertens, J.8
Lortholary, O.9
Kauffman, C.A.10
Denning, D.W.11
Patterson, T.F.12
Maschmeyer, G.13
Bille, J.14
Dismukes, W.E.15
Herbrecht, R.16
Hope, W.W.17
Kibbler, C.C.18
Kullberg, B.J.19
Marr, K.A.20
Muñoz, P.21
Odds, F.C.22
Perfect, J.R.23
Restrepo, A.24
Ruhnke, M.25
Segal, B.H.26
Sobel, J.D.27
Sorrell, T.C.28
Viscoli, C.29
Wingard, J.R.30
Zaoutis, T.31
Bennett, J.E.32
more..
-
34
-
-
49449103740
-
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
-
PMid:18637757 PMCid:2671230
-
Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin Infect Dis 2008; 47: 674-683. http://dx.doi.org/10.1086/590566 PMid:18637757 PMCid:2671230
-
(2008)
Clin Infect Dis
, vol.47
, pp. 674-683
-
-
Segal, B.H.1
Herbrecht, R.2
Stevens, D.A.3
Ostrosky-Zeichner, L.4
Sobel, J.5
Viscoli, C.6
Walsh, T.J.7
Maertens, J.8
Patterson, T.F.9
Perfect, J.R.10
Dupont, B.11
Wingard, J.R.12
Calandra, T.13
Kauffman, C.A.14
Graybill, J.R.15
Baden, L.R.16
Pappas, P.G.17
Bennett, J.E.18
Kontoyiannis, D.P.19
Cordonnier, C.20
Viviani, M.A.21
Bille, J.22
Almyroudis, N.G.23
Wheat, L.J.24
Graninger, W.25
Bow, E.J.26
Holland, S.M.27
Kullberg, B.J.28
Dismukes, W.E.29
De Pauw, B.E.30
more..
-
35
-
-
0029095282
-
Use of amphotericin B with azole antifungal drugs: what are we doing?
-
PMid:8540690 PMCid:162855
-
Sugar AM. Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother. 1995; 39:1907-1912. PMid:8540690 PMCid:162855
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1907-1912
-
-
Sugar, A.M.1
-
36
-
-
0026530435
-
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
-
Denning DW, Hanson LH, Perlman AM, Stevens DA. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992; 15: 21-34. http://dx.doi.org/10.1016/0732-8893(92)90053-V
-
(1992)
Diagn Microbiol Infect Dis
, vol.15
, pp. 21-34
-
-
Denning, D.W.1
Hanson, L.H.2
Perlman, A.M.3
Stevens, D.A.4
-
37
-
-
35349019258
-
Combination antifungals: an update
-
PMid:17914921
-
Segal BH, Steinbach WJ. Combination antifungals: an update. Expert Rev Anti Infect Ther 2007; 5: 883-892. http://dx.doi.org/10.1586/14787210.5.5.883 PMid:17914921
-
(2007)
Expert Rev Anti Infect Ther
, vol.5
, pp. 883-892
-
-
Segal, B.H.1
Steinbach, W.J.2
-
38
-
-
77950363815
-
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B
-
PMid:19887460
-
Cornely OA, Maertens J, Bresnik M, Ullmann AJ, Ebrahimi R, Herbrecht R. Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B. J Antimicrob Chemother. 2010;65:114-117. http://dx.doi.org/10.1093/jac/dkp397 PMid:19887460
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 114-117
-
-
Cornely, O.A.1
Maertens, J.2
Bresnik, M.3
Ullmann, A.J.4
Ebrahimi, R.5
Herbrecht, R.6
-
39
-
-
84857471314
-
Combination of voriconazole and anidulafungin as primary therapy in hematologic patients
-
Cetkovsky P, Kouba M, Markova M, Kolar M, Hricinova M, Mertova J, Salek C, Vitek A, Cermak J, Soukup P. Combination of voriconazole and anidulafungin as primary therapy in hematologic patients. Biol Blood Marrow Transplant. 2010; 16: S264. http://dx.doi.org/10.1016/j.bbmt.2009.12.328
-
(2010)
Biol Blood Marrow Transplant
, vol.16
-
-
Cetkovsky, P.1
Kouba, M.2
Markova, M.3
Kolar, M.4
Hricinova, M.5
Mertova, J.6
Salek, C.7
Vitek, A.8
Cermak, J.9
Soukup, P.10
-
40
-
-
58149120831
-
Granulocyte transfusion therapy: a new era?
-
PMid:19057197 PMCid:2674763
-
Dale DC, Price TH. Granulocyte transfusion therapy: a new era? Curr Opin Hematol 2009;16:1-2. http://dx.doi.org/10.1097/MOH.0b013e32831d7953 PMid:19057197 PMCid:2674763
-
(2009)
Curr Opin Hematol
, vol.16
, pp. 1-2
-
-
Dale, D.C.1
Price, T.H.2
|